Sure, President Bush can say that the U.S. government won't fund stem cell research, but believe me, Japan is applauding. Because they will just do it first and get all the patents.

Kevin J. Anderson’s quote reflects his criticism of the U.S. government's stance on stem cell research, particularly during President George W. Bush’s administration, which imposed restrictions on federal funding for this area of scientific inquiry. Anderson implies that while the U.S. might choose not to invest in stem cell research, other nations, like Japan, are more than willing to take the lead and reap the benefits of the breakthroughs that result. His comment points out that in the competitive world of scientific innovation, failure to act quickly could result in other countries taking the lead and securing patents on important discoveries.

The reference to Japan applauding the lack of American action highlights how countries around the world were eager to capitalize on advancements in biotechnology and medical research. Anderson's quote underscores the idea that countries competing for technological dominance can gain an economic and strategic advantage if others lag behind. He suggests that by not prioritizing stem cell research, the U.S. risks falling behind in a key area of scientific progress, both in terms of innovation and the potential for economic growth derived from patents and commercial applications.

Anderson’s words also reflect a broader critique of how political decisions can impact scientific progress. By suggesting that the U.S. government might hinder scientific research through restrictions, he highlights the tension between politics and innovation. The debate over stem cell research was contentious, with ethical and moral concerns influencing political decisions, particularly on funding. Anderson, however, emphasizes the global nature of scientific development, where nations with fewer restrictions can move forward, leaving others behind.

In essence, Anderson’s quote is a warning about the potential consequences of political inaction in the face of rapidly advancing global technology. It serves as a critique of the U.S. government's decision to limit funding for stem cell research, pointing out that in a competitive, globalized world, such decisions could have far-reaching implications, including losing out on valuable scientific discoveries and economic opportunities.